GXMC
ANAC

Global X Management Company’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Global X Management Company’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-220
Closed -$17K – 1049
2015
Q2 		$17K Buy
+220
New +$14.4K ﹤0.01% 504
2014
Q3 		– Sell
-1,493
Closed -$26K – 588
2014
Q2 		$26K Buy
+1,493
New +$24K ﹤0.01% 415

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Global X Management Company's ANAC Position: Q3 2015 in Review

Global X Management Company sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2015, closing a stake of 220 shares — an estimated $17K sold.

Global X Management Company first reported a position in ANAC in Q2 2014 and held it in 2 quarters. The position peaked at $26K in Q2 2014. 213 funds tracked by Wall St. Rank hold ANAC as of Q3 2015.

  • Global X Management Company reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2015 after selling out during the quarter.
  • Global X Management Company sold 220 ANACOR PHARMACEUTICALS INC COM shares in Q3 2015, an estimated $17K.
  • Global X Management Company first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 2 quarters.
  • Global X Management Company's ANACOR PHARMACEUTICALS INC COM position peaked at $26K in Q2 2014.
  • 213 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2015.

Based on Global X Management Company's 13F filing for Q3 2015, filed 12 Nov 2015.